Improving red cell life
...and real life
Our Aim
Premedinn is a start-up comprised of professionals with expertise in several fields of medicine and a particular focus on managing health problems with multidisciplinary approach, efficacy, safety and sustainability.
Clinical Scientist Team
Dr. Miguel G. Uriol Rivera
Nephrologist Md. PhD.
Consultant Nephrologist >20 years.
Doctoral thesis in renal anaemia and 87+ publications (articles, posters) in nephropathies.
Awarded by the Spanish of Nephrology Society as best work on: Clinical benefits for hemodialysis patients: Benefits of the Paricalcitol on anemia of inflammation in dialysis patients under erythropoietic stimulating agents.
Candidate to Extraordinary PhD Award by the Universidad de las Islas Baleares.
Javier Molina Infante
Digestologist Md. PhD.
Consultant Gastroenterologist > 20 years
United European Gastroenterology Rising Star 2015
Head of Spanish Research Group on Eosinophilic Esophagitis and Gastrointestinal Eosinophilic Disorders at CIBERREHD platform
Extraordinary PhD Award Universidad Complutense de Madrid
Dr. Pablo Molina
Scientific Advisor
Pablo Molina is a distinguished nephrologist currently serving at the Hospital Universitari Dr Peset. Additionally, he holds a position as an associate lecturer in Medicine at the University of Valencia in Spain. His primary research interests encompass hemodialysis. He also delves deeply into nutrition, metabolism, and bone disease in patients with chronic kidney disease. Pablo is an esteemed member of the European Renal Nutrition (ERN) working group under the European Renal Association. Furthermore, he is a theme editor for Nephrology, Dialysis and Transplantation
Severe public health problem
Anaemia of inflammation
>1 billion individuals affected worldwide
Current treatments have relevant safety concerns
Increases mortality
Increases healthcare costs x 2
Anaemia of inflamation is a major clinical unmeet need
Anaemia of inflammation project
Clinical development
- Studies
- Clinical trial
- Doctoral thesis
Strategic Partners
Patent
- Priority data
- Intelectual property rights
- MIA Patents
PREMEDINN, S.L.
- Comercial and business structure
Entering the International Expansion Phase: Investment Opportunities Available
Innovative solution for anaemia of inflammation
Innovative solution developed by Premedinn
Treat 4 targets
Inflammation
Erythropoiesis
Red blood cell life span
Anti-aging
Worldwide technology protection
Potential target diseases
Kidneys
Heart
Lungs
News
Interview with CEO of Premedinn, at OK Baleares
Premedinn, the startup form the Balearic Islands willing to revolutionize the treatment of anemia in the world.
OCT 2023
The Direct Effect of the Vitamin D Receptor Activation in Hemoglobin: Opening a New Treatment Approach in Renal Anaemia
Poster presentation at the American Society of Nephrology’s Kidney Week 2022 meeting in Orlando, Florida.
NOV 2022
Kidney week 2022 highlights at Renal&Urology News
Paricalcitol Inedepently Increases Hemoglobin Levels. Investigation results represent a real opportunity for exploring the use of paricalcitol as a safe and effective therapy for renal anemia,
NOV 2022
Contact us
Partners
Intellectual Property